Building better bones and tissue in the lab

December 15, 2008

Tissue engineering holds great promise for the treatment of conditions such as arthritis, osteoporosis, fibrosis, periodontal disease and traumatic injuries. However, bone and cartilage currently produced in the laboratory don't have sufficient strength to function in the body so they're not clinically viable. Dr. Douglas Hamilton, a dental researcher with the Schulich School of Medicine & Dentistry at The University of Western Ontario has received funding from the Canada Foundation for Innovation (CFI) to try to find solutions to that problem.

Hamilton and the Centre for the Study of Biomaterials and Tissue Regeneration has received nearly $163,000 from CFI to purchase specialized equipment to assess cell responses to a variety of mechanical forces and biomaterial types using state-of-the-art molecular biology and imaging techniques.

"In many instances our ability to help tissues such as bone to repair, is limited as we don't fully understand how human tissues respond to the presence of artificial materials. This becomes even more problematic in tissues that are loaded due to normal human activity," says Hamilton. "With the funding from the CFI, we are establishing an innovative laboratory that will allows us to study how cells respond to both mechanical stimulation and biomaterials such as titanium at the same time. We anticipate learning much about how cells sense their environment and subsequently regenerate tissues, which will be important in orthopaedics, dentistry, and cardiovascular medicine."

CFI just announced $45.5 million in new funds to support 251 projects across the country. Western received a total of $1.3 million to fund five research projects. The four other recipients are:
-end-
The CFI is an independent corporation created by the Government of Canada to fund research infrastructure. A complete list of funded projects can be found at www.innovation.ca .

University of Western Ontario

Related Metabolic Syndrome Articles from Brightsurf:

Metabolic syndrome linked to worse outcomes for COVID-19 patients
Patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity and diabetes were over three times more likely to die from the disease, according to a new Tulane University study published in Diabetes Care.

New study finds that menopause increases risk of metabolic syndrome
Perimenopause is a time when women become more vulnerable to a number of health problems.

Does sarcoponic obesity link to metabolic syndrome? An issue that needs clarification
A systematic review and meta-analysis with the main scope to provide benchmark data on the prevalence of metabolic syndrome (Mets) among individuals with Sarcopenic Obesity (SO), as well as to detect the potential association between the presence of SO and the higher risk of Mets.

Socioeconomics, metabolic syndrome, and osteopenia in postmenopausal women
The increased prevalence of metabolic syndrome and osteoporosis in postmenopausal women has prompted multiple research studies to understand why.

Metabolic syndrome associated with increased risk of blood clot recurrence
People with metabolic syndrome -- a set of conditions including obesity, impaired glucose metabolism, elevated levels of fats and cholesterol in the blood, and high blood pressure - are more likely to experience recurrent blood clots, according to a new study published today in Blood Advances.

Hops compounds help with metabolic syndrome while reducing microbiome diversity
Compounds from hops may combat metabolic syndrome by changing the gut microbiome and altering the metabolism of acids produced in the liver, new research suggests.

Metabolic syndrome: New use for an old drug
The discovery, described in a study by Cosbi and Cimec of the University of Trento published today in Nature Communications, confirms the effectiveness of repurposing, the new frontier of pharmacological research.

Three easy measures to predict metabolic syndrome in elderly
A new study found a surprisingly high rate of metabolic syndrome among individuals aged 60-100 years.

Nanovaccine boosts immunity in sufferers of metabolic syndrome
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

Natural sugar defends against metabolic syndrome, in mice
New research, in mice, indicates that a natural sugar called trehalose blocks glucose from the liver and activates a gene that boosts insulin sensitivity, reducing the chance of developing diabetes.

Read More: Metabolic Syndrome News and Metabolic Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.